EMEA-002214-PIP01-17

Key facts

Active substance
Inclisiran sodium
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0321/2018
PIP number
EMEA-002214-PIP01-17
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of elevated cholesterol
Route(s) of administration
Subcutaneous use
Contact for public enquiries
The Medicines Company UK Ltd.

Tel. +1 9732906000
E-mail: communications@theorionprjt.com

 

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating